232 related articles for article (PubMed ID: 20709073)
1. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.
Shi J; Zhang YW; Yang Y; Zhang L; Wei L
J Mol Cell Cardiol; 2010 Nov; 49(5):819-28. PubMed ID: 20709073
[TBL] [Abstract][Full Text] [Related]
2. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy.
Shi J; Zhang YW; Summers LJ; Dorn GW; Wei L
J Mol Cell Cardiol; 2008 Mar; 44(3):551-60. PubMed ID: 18178218
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.
Adams JW; Sakata Y; Davis MG; Sah VP; Wang Y; Liggett SB; Chien KR; Brown JH; Dorn GW
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10140-5. PubMed ID: 9707614
[TBL] [Abstract][Full Text] [Related]
5. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol kinase zeta rescues G alpha q-induced heart failure in transgenic mice.
Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Koyama Y; Goto K; Mende U; Kubota I
Circ J; 2008 Feb; 72(2):309-17. PubMed ID: 18219172
[TBL] [Abstract][Full Text] [Related]
7. MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq.
Minamino T; Yujiri T; Terada N; Taffet GE; Michael LH; Johnson GL; Schneider MD
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3866-71. PubMed ID: 11891332
[TBL] [Abstract][Full Text] [Related]
8. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
9. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
Okamoto R; Li Y; Noma K; Hiroi Y; Liu PY; Taniguchi M; Ito M; Liao JK
FASEB J; 2013 Apr; 27(4):1439-49. PubMed ID: 23271052
[TBL] [Abstract][Full Text] [Related]
10. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
[TBL] [Abstract][Full Text] [Related]
11. Galphaq expression activates EGFR and induces Akt mediated cardiomyocyte survival: dissociation from Galphaq mediated hypertrophy.
Howes AL; Miyamoto S; Adams JW; Woodcock EA; Brown JH
J Mol Cell Cardiol; 2006 May; 40(5):597-604. PubMed ID: 16466740
[TBL] [Abstract][Full Text] [Related]
12. RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.
Lauriol J; Keith K; Jaffré F; Couvillon A; Saci A; Goonasekera SA; McCarthy JR; Kessinger CW; Wang J; Ke Q; Kang PM; Molkentin JD; Carpenter C; Kontaridis MI
Sci Signal; 2014 Oct; 7(348):ra100. PubMed ID: 25336613
[TBL] [Abstract][Full Text] [Related]
13. Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
Miyamoto S; Del Re DP; Xiang SY; Zhao X; Florholmen G; Brown JH
J Cardiovasc Transl Res; 2010 Aug; 3(4):330-43. PubMed ID: 20559774
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
[TBL] [Abstract][Full Text] [Related]
15. Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility.
Sabri A; Wilson BA; Steinberg SF
Circ Res; 2002 May; 90(8):850-7. PubMed ID: 11988485
[TBL] [Abstract][Full Text] [Related]
16. Raf-mediated cardiac hypertrophy in adult Drosophila.
Yu L; Daniels J; Glaser AE; Wolf MJ
Dis Model Mech; 2013 Jul; 6(4):964-76. PubMed ID: 23580199
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
Satoh M; Matter CM; Ogita H; Takeshita K; Wang CY; Dorn GW; Liao JK
Circulation; 2007 Jun; 115(25):3197-204. PubMed ID: 17562954
[TBL] [Abstract][Full Text] [Related]
18. Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure.
Yue X; Yang X; Lin X; Yang T; Yi X; Dai Y; Guo J; Li T; Shi J; Wei L; Fan GC; Chen C; Chang J
Cell Death Dis; 2014 Jun; 5(6):e1284. PubMed ID: 24901055
[TBL] [Abstract][Full Text] [Related]
19. Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice.
Dorn GW; Tepe NM; Lorenz JN; Koch WJ; Liggett SB
Proc Natl Acad Sci U S A; 1999 May; 96(11):6400-5. PubMed ID: 10339599
[TBL] [Abstract][Full Text] [Related]
20. Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation.
Diwan A; Wansapura J; Syed FM; Matkovich SJ; Lorenz JN; Dorn GW
Circulation; 2008 Jan; 117(3):396-404. PubMed ID: 18178777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
